ISO/TC 212
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 72141 | ISO/TS 16782:2016 | Clinical laboratory testing — Criteria for acceptable lots of dehydrated Mueller-Hinton agar and broth for antimicrobial susceptibility testing | Standarts spēkā |
| 69802 | ISO 20166-2:2018 | Molecular in vitro diagnostic examinations — Specifications for pre-examinations processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 2: Isolated proteins | Standarts spēkā |
| 71293 | ISO 35001:2019 | Biorisk management for laboratories and other related organisations | Standarts spēkā |
| 67215 | ISO 20184-1:2018 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 1: Isolated RNA | Standarts spēkā |
| 69803 | ISO 20166-3:2018 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 3: Isolated DNA | Standarts spēkā |
| 54976 | ISO 15197:2013 | In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus | Standarts spēkā |
| 75442 | ISO 20166-4:2021 | Molecular in vitro diagnostic examinations — Specifications for preexamination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 4: In situ detection techniques | Standarts spēkā |
| 69445 | ISO/TS 20914:2019 | Medical laboratories — Practical guidance for the estimation of measurement uncertainty | Standarts spēkā |
| 57706 | ISO/PRF 16782 | Clinical laboratory testing — Criteria for acceptable lots of dehydrated Mueller-Hinton agar and broth for antimicrobial susceptibility testing | Standarts spēkā |
| 69455 | ISO 20916:2019 | In vitro diagnostic medical devices — Clinical performance studies using specimens from human subjects — Good study practice | Standarts spēkā |
Displaying 11-20 of 146 results.